Biohaven (BHVN) EPS (Weighted Average and Diluted) (2021 - 2026)
Biohaven's (BHVN) quarterly EPS (Weighted Average and Diluted) came in at -$0.88 in Q1 2026, up 59.45% year-on-year from -$0.55 in Q1 2025, and up 21.43% quarter-over-quarter from -$1.12 in Q4 2025.
Biohaven (BHVN) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Biohaven has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.88 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.88, up 59.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.58 (up 39.94% YoY), and the FY2025 annual result was -$6.86, up 26.08% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.88 for Q1 2026 at Biohaven, up from -$1.12 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.88 in Q1 2026 to a low of -$5.16 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$1.78 (2024), against an average of -$2.09.
- Across the five-year window, EPS (Weighted Average and Diluted) soared 74.42% in 2023 and plunged 175.76% in 2024, its largest moves.
- Biohaven's EPS (Weighted Average and Diluted) stood at -$3.37 in 2022, then soared by 44.51% to -$1.87 in 2023, then increased by 4.81% to -$1.78 in 2024, then soared by 37.08% to -$1.12 in 2025, then advanced by 21.43% to -$0.88 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.88 (Q1 2026), -$1.12 (Q4 2025), and -$1.64 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | -0.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.88 |
| Dec 31, 2025 | -1.12 |
| Sep 30, 2025 | -1.64 |
| Jun 30, 2025 | -1.94 |
| Mar 31, 2025 | -2.17 |
| Dec 31, 2024 | -1.78 |
| Sep 30, 2024 | -1.70 |
| Jun 30, 2024 | -3.64 |
| Mar 31, 2024 | -2.20 |
| Dec 31, 2023 | -1.87 |
| Sep 30, 2023 | -1.50 |
| Jun 30, 2023 | -1.32 |
| Mar 31, 2023 | -1.03 |
| Dec 31, 2022 | -3.37 |
| Sep 30, 2022 | -1.75 |
| Jun 30, 2022 | -5.16 |
| Mar 31, 2022 | -2.46 |
| Dec 31, 2021 | -1.32 |
| Sep 30, 2021 | -1.38 |